Primary And Secondary Hypogonadism, Menopause And
Primary And Secondary Hypogonadism, Menopause And

Author: Primary And Secondary Hypogonadism, Menopause And

The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against using testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of ailments affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated decrease in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study included about 800 elderly men with low testosterone and symptoms associated with this condition, such testosterone therapy side effects hair loss [webpage] as sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart health was carefully monitored.

Studies have shown that testosterone deficiency is related to several critical health issues including diabetes, obesity, metabolic syndrome, and bone fractures Guys who meet medical standards for treatment should receive therapy. Actually, your testosterone levels have likely been slowly declining for quite some time, a downfall that typically begins around age 30.

No clear lower limit of testosterone was confirmed; yet 15 ng per dL (0.5 nmol per L) usually is used. One study 38 found that women with 0 to 10 ng per dL (0 to 0.3 nmol per L) had noticeably decreased sexual desire in all scenarios and absent or markedly decreased orgasms. As a result of studies in this way, supplemented with anecdotal evidence, many women are started on testosterone therapy. Most women can expect to spend one third of their lives in the postmenopausal period. Depression, anger, moodiness, insomnia, and lack of well being are common criticisms of postmenopausal women.